News

Article

Rheumatoid Arthritis Quiz: Swapping Biosimilars for Reference Products in RA

Author(s):

Ingrid Torjesen

Biosimilars can be considerably cheaper for patients compared with the reference drug. Test your knowledge of when reference products can be swapped for biosimilars with this quiz.

Is the following statement true or false?

A pharmacist may substitute a biosimilar for the reference product without the intervention of the prescribing health care provider in some states.


Related Videos
Duloxetine for Patients with COPD Suffering from Comorbid Depression
Enhancing Standards for Ethical Responsibilities within Clinical Research
Jennifer Flemming, MD | Credit: AASLD
Related Content
Sizheng Steven Zhao, MBChB, PhD, Clinical Lecturer at the Centre for Musculoskeletal Research, University of Manchester, United Kingdom
January 21st 2025

JAKi Treatment for Psoriatic Arthritis Not Associated With Increased CVD, VTE, Cancer Risk

Victoria Johnson
Default thumbnail for The Medical Sisterhood podcast
January 16th 2025

Medical Sisterhood: Polished and Powerful—Women Leading the Charge in Advocacy

Mona Shahriari, MD, FAAD Shadi Kourosh, MD, MPH
Dupilumab Effective for Pediatric Patients with Atopic Dermatitis at 16 Weeks
January 21st 2025

Dupilumab Effective for Pediatric Patients with Atopic Dermatitis at 16 Weeks

Tim Smith
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
January 16th 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Credit: US Food and Drug Administration
January 21st 2025

FDA Approves Esketamine as First Monotherapy for Treatment-Resistant Depression

Chelsie Derman
Ben Underwood, PhD I Credit: LinkedIn
January 21st 2025

Antimicrobials, Vaccinations, Anti-inflammatories Linked to Lower Dementia Risk

Chelsie Derman
© 2025 MJH Life Sciences

All rights reserved.